Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Breast Cancer

  Free Subscription


10.04.2017

1 AJR Am J Roentgenol
2 Ann Oncol
1 Ann Surg Oncol
8 Anticancer Res
2 BMC Cancer
1 BMJ
2 Breast Cancer
1 Breast Cancer Res
7 Breast Cancer Res Treat
1 Breast J
2 Cancer
1 Cancer Epidemiol Biomarkers Prev
4 Clin Breast Cancer
1 Clin Cancer Res
3 Int J Radiat Oncol Biol Phys
2 J Clin Oncol
19 J Natl Cancer Inst
2 J Nucl Med
1 JAMA
1 Lancet Oncol
1 Oncogene
1 Oncol Rep
3 PLoS One
1 Radiology
1 Radiother Oncol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJR Am J Roentgenol

  1. FERRE R, Omeroglu A, Mesurolle B
    Sonographic Appearance of Lesions Diagnosed as Lobular Neoplasia at Sonographically Guided Biopsies.
    AJR Am J Roentgenol. 2017 Jan 11:1-7. doi: 10.2214/AJR.15.15056.
    PubMed     Text format     Abstract available


    Ann Oncol

  2. TREDAN O, Menetrier-Caux C, Ray-Coquard I, Garin G, et al
    ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients.
    Ann Oncol. 2017 Mar 24. doi: 10.1093.
    PubMed     Text format    

  3. YERUSHALMI R, Dong B, Chapman JW, Goss PE, et al
    Impact of baseline BMI and weight change in CCTG adjuvant breast cancer trials.
    Ann Oncol. 2017 Mar 31. doi: 10.1093.
    PubMed     Text format     Abstract available


    Ann Surg Oncol

  4. ZHU L, Chen K, Jacobs LK, Aft R, et al
    Axillary Lymphadenectomy in Sentinel Lymph Node-Positive Breast Cancer.
    Ann Surg Oncol. 2017 Mar 31. doi: 10.1245/s10434-017-5849.
    PubMed     Text format    


    Anticancer Res

  5. JELINEK M, Kabelova A, Sramek J, Seitz J, et al
    Differing Mechanisms of Death Induction by Fluorinated Taxane SB-T-12854 in Breast Cancer Cells.
    Anticancer Res. 2017;37:1581-1590.
    PubMed     Text format     Abstract available

  6. ACUNA UM, Curley RW Jr, Fatima N, Ahmed S, et al
    Differential Effect of Wortmannolone Derivatives on MDA-MB-231 Breast Cancer Cells.
    Anticancer Res. 2017;37:1617-1623.
    PubMed     Text format     Abstract available

  7. DAS T, Nair RR, Green R, Padhee S, et al
    Actinomycin D Down-regulates SOX2 Expression and Induces Death in Breast Cancer Stem Cells.
    Anticancer Res. 2017;37:1655-1663.
    PubMed     Text format     Abstract available

  8. KIM KY, Park KI, Kim SH, Yu SN, et al
    Salinomycin Induces Reactive Oxygen Species and Apoptosis in Aggressive Breast Cancer Cells as Mediated with Regulation of Autophagy.
    Anticancer Res. 2017;37:1747-1758.
    PubMed     Text format     Abstract available

  9. BYSTRICKY B, Jurisova S, Karaba M, Minarik G, et al
    Relationship Between Circulating Tumor Cells and Tissue Plasminogen Activator in Patients with Early Breast Cancer.
    Anticancer Res. 2017;37:1787-1791.
    PubMed     Text format     Abstract available

  10. OKU Y, Nishiya N, Tsuda K, Shibazaki M, et al
    Dynamic Phenotypic Transition of Breast Cancer Cells In Vitro Revealed by Self-floating Cell Culture.
    Anticancer Res. 2017;37:1793-1797.
    PubMed     Text format     Abstract available

  11. THANGARAJAH F, Enninga I, Malter W, Hamacher S, et al
    A Retrospective Analysis of Ki-67 Index and its Prognostic Significance in Over 800 Primary Breast Cancer Cases.
    Anticancer Res. 2017;37:1957-1964.
    PubMed     Text format     Abstract available

  12. INOUE Y, Yamashita N, Tokunaga E, Tanaka K, et al
    A Locally Advanced Breast Cancer that Achieved pCR with Pertuzumab, Trastuzumab and Docetaxel: Case Report.
    Anticancer Res. 2017;37:1917-1921.
    PubMed     Text format     Abstract available


    BMC Cancer

  13. MELVIN JC, Garmo H, Holmberg L, Hammar N, et al
    Glucose and lipoprotein biomarkers and breast cancer severity using data from the Swedish AMORIS cohort.
    BMC Cancer. 2017;17:246.
    PubMed     Text format     Abstract available

  14. JOVANOVIC B, Sheng Q, Seitz RS, Lawrence KD, et al
    Comparison of triple-negative breast cancer molecular subtyping using RNA from matched fresh-frozen versus formalin-fixed paraffin-embedded tissue.
    BMC Cancer. 2017;17:241.
    PubMed     Text format     Abstract available


    BMJ

  15. WISE J
    Breast screening benefits have been overstated, Danish study finds.
    BMJ. 2017;356:j94.
    PubMed     Text format    


    Breast Cancer

  16. MALEK-HOSSEINI Z, Jelodar S, Talei A, Ghaderi A, et al
    Elevated Syndecan-1 levels in the sera of patients with breast cancer correlate with tumor size.
    Breast Cancer. 2017 Apr 5. doi: 10.1007/s12282-017-0773.
    PubMed     Text format     Abstract available

  17. OGIYA A, Yamazaki K, Horii R, Shien T, et al
    Erratum to: Post-relapse survival in patients with the early and late distant recurrence in estrogen receptor-positive HER2-negative breast cancer.
    Breast Cancer. 2017 Apr 4. doi: 10.1007/s12282-017-0771.
    PubMed     Text format    


    Breast Cancer Res

  18. YAGHJYAN L, Arao R, Brokamp C, O'Meara ES, et al
    Association between air pollution and mammographic breast density in the Breast Cancer Surveilance Consortium.
    Breast Cancer Res. 2017;19:36.
    PubMed     Text format     Abstract available


    Breast Cancer Res Treat

  19. MANDELBLATT JS, Cai L, Luta G, Kimmick G, et al
    Frailty and long-term mortality of older breast cancer patients: CALGB 369901 (Alliance).
    Breast Cancer Res Treat. 2017 Mar 31. doi: 10.1007/s10549-017-4222.
    PubMed     Text format     Abstract available

  20. THOMAS LN, Chedrawe ER, Barnes PJ, Too CK, et al
    Prolactin/androgen-inducible carboxypeptidase-D increases with nitrotyrosine and Ki67 for breast cancer progression in vivo, and upregulates progression markers VEGF-C and Runx2 in vitro.
    Breast Cancer Res Treat. 2017 Mar 31. doi: 10.1007/s10549-017-4223.
    PubMed     Text format     Abstract available

  21. ANDREANO A, Rebora P, Valsecchi MG, Russo AG, et al
    Adherence to guidelines and breast cancer patients survival: a population-based cohort study analyzed with a causal inference approach.
    Breast Cancer Res Treat. 2017 Apr 1. doi: 10.1007/s10549-017-4210.
    PubMed     Text format     Abstract available

  22. LEE GE, Mayer EL, Partridge A
    Prognosis of pregnancy-associated breast cancer.
    Breast Cancer Res Treat. 2017 Apr 1. doi: 10.1007/s10549-017-4224.
    PubMed     Text format     Abstract available

  23. GOMEZ SL, Von Behren J, McKinley M, Clarke CA, et al
    Breast cancer in Asian Americans in California, 1988-2013: increasing incidence trends and recent data on breast cancer subtypes.
    Breast Cancer Res Treat. 2017 Apr 1. doi: 10.1007/s10549-017-4229.
    PubMed     Text format     Abstract available

  24. DIECI MV, Frassoldati A, Generali D, Bisagni G, et al
    Erratum to: Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2- breast cancer: results from two prospective trials.
    Breast Cancer Res Treat. 2017 Apr 3. doi: 10.1007/s10549-017-4219.
    PubMed     Text format    

  25. MONFORT SM, Pan X, Patrick R, Ramaswamy B, et al
    Gait, balance, and patient-reported outcomes during taxane-based chemotherapy in early-stage breast cancer patients.
    Breast Cancer Res Treat. 2017 Apr 3. doi: 10.1007/s10549-017-4230.
    PubMed     Text format     Abstract available


    Breast J

  26. DARVISHI B, Farahmand L, Majidzadeh K
    Patterns of Cancer Stem Cell Negotiation with Breast Cancer Anti-angiogenic Therapy.
    Breast J. 2017 Mar 30. doi: 10.1111/tbj.12806.
    PubMed     Text format    


    Cancer

  27. CASSIDY RJ, Liu Y, Kahn ST, Jegadeesh NK, et al
    The role of postmastectomy radiotherapy in women with pathologic T3N0M0 breast cancer.
    Cancer. 2017 Apr 7. doi: 10.1002/cncr.30675.
    PubMed     Text format     Abstract available

  28. LIANG X, Margolis KL, Hendryx M, Reeves K, et al
    Effect of depression before breast cancer diagnosis on mortality among postmenopausal women.
    Cancer. 2017 Apr 7. doi: 10.1002/cncr.30688.
    PubMed     Text format     Abstract available


    Cancer Epidemiol Biomarkers Prev

  29. FENG Y, Rhie SK, Huo D, Ruiz-Narvaez EA, et al
    Characterizing Genetic Susceptibility to Breast Cancer in Women of African Ancestry.
    Cancer Epidemiol Biomarkers Prev. 2017 Apr 4. pii: cebp.0567.2016.
    PubMed     Text format     Abstract available


    Clin Breast Cancer

  30. BERNARDO A, Palumbo R, Pedersini R, Rota Caremoli E, et al
    Nab-Paclitaxel in Advanced HER2-negative Breast Cancer Patients: Efficacy and Safety Beyond Clinical Trials.
    Clin Breast Cancer. 2017 Mar 9. pii: S1526-8209(16)30359.
    PubMed     Text format     Abstract available

  31. VIDAL GA, Chen M, Sheth S, Svahn T, et al
    Phase I Trial of Everolimus and Capecitabine in Metastatic HER2- Breast Cancer.
    Clin Breast Cancer. 2017 Mar 16. pii: S1526-8209(16)30410.
    PubMed     Text format     Abstract available

  32. CHAND AR, Ziauddin MF, Tang SC
    Can Locoregionally Recurrent Breast Cancer Be Cured?
    Clin Breast Cancer. 2017 Mar 2. pii: S1526-8209(17)30113.
    PubMed     Text format     Abstract available

  33. CHAPMAN JW, Liu S, Leung S, Nielsen TO, et al
    Competing Risks of Mortality by PAM50 Intrinsic Subtype of British Columbia Tamoxifen-Treated Cohort of Postmenopausal Patients With Breast Cancer.
    Clin Breast Cancer. 2017 Jan 20. pii: S1526-8209(16)30362.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  34. ASSADIPOUR Y, Zacharakis N, Crystal JS, Prickett TD, et al
    Characterization of an Immunogenic Mutation in a Patient with Metastatic Triple Negative Breast Cancer.
    Clin Cancer Res. 2017 Apr 4. pii: clincanres.1423.2016.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  35. MONTEN C, Lievens Y, Olteanu LA, Paelinck L, et al
    Highly Accelerated Irradiation in 5 Fractions (HAI-5): Feasibility in Elderly Women With Early or Locally Advanced Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2017 Feb 1. pii: S0360-3016(17)30292.
    PubMed     Text format     Abstract available

  36. WRIGHT JL, Parekh A, Pollock YY, Schoenborn N, et al
    Use of Geriatric Assessment Tools in Selecting Therapies in Women Aged >/=70 Years With Hormone Receptor-Positive Early-Stage Breast Cancer: Preliminary Experience With a Quality Improvement Initiative.
    Int J Radiat Oncol Biol Phys. 2017 Jan 29. pii: S0360-3016(17)30272.
    PubMed     Text format     Abstract available

  37. WANG SY, Kelly G, Gross C, Killelea BK, et al
    Information Needs of Older Women With Early-Stage Breast Cancer When Making Radiation Therapy Decisions.
    Int J Radiat Oncol Biol Phys. 2017 Feb 9. pii: S0360-3016(17)30309.
    PubMed     Text format     Abstract available


    J Clin Oncol

  38. SONNENBLICK A, Agbor-Tarh D, Bradbury I, Di Cosimo S, et al
    Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2-Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized Trial.
    J Clin Oncol. 2017 Mar 13:JCO2016697722. doi: 10.1200/JCO.2016.69.7722.
    PubMed     Text format     Abstract available

  39. BORGQUIST S, Giobbie-Hurder A, Ahern TP, Garber JE, et al
    Cholesterol, Cholesterol-Lowering Medication Use, and Breast Cancer Outcome in the BIG 1-98 Study.
    J Clin Oncol. 2017;35:1179-1188.
    PubMed     Text format     Abstract available


    J Natl Cancer Inst

  40. SCHMIDT MK, van den Broek AJ, Tollenaar RA, Smit VT, et al
    Breast Cancer Survival of BRCA1/BRCA2 Mutation Carriers in a Hospital-Based Cohort of Young Women.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available

  41. ERREN TC, Morfeld P, Gross JV
    RE: Night Shiftwork and Breast Cancer Incidence: Three Prospective Studies and Meta-analysis of Published Studies.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format    

  42. BYRNE C, Ursin G, Martin CF, Peck JD, et al
    Mammographic Density Change With Estrogen and Progestin Therapy and Breast Cancer Risk.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available

  43. MA R, Karthik GM, Lovrot J, Haglund F, et al
    Estrogen Receptor beta as a Therapeutic Target in Breast Cancer Stem Cells.
    J Natl Cancer Inst. 2017;109:1-14.
    PubMed     Text format     Abstract available

  44. GARRIDO-CASTRO AC, Winer EP
    Genomic Profiling in Node-Positive ER-Positive Early Breast Cancer: Can Tumor Biology Guide Locoregional Therapy?
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format    

  45. STEVENS RG
    RE: Night Shift Work and Breast Cancer Incidence: Three Prospective Studies and Meta-analysis of Published Studies.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format    

  46. SHAFAEE MN, Ellis MJ
    Breast Cancer Patient-Derived Xenografts: Pros, Cons, and Next Steps.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format    

  47. GINGRAS I, Holmes E, De Azambuja E, Nguyen DH, et al
    Regional Nodal Irradiation After Breast Conserving Surgery for Early HER2-Positive Breast Cancer: Results of a Subanalysis From the ALTTO Trial.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available

  48. POLLACK CE, Soulos PR, Herrin J, Xu X, et al
    The Impact of Social Contagion on Physician Adoption of Advanced Imaging Tests in Breast Cancer.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available

  49. VISSCHER DW, Frank RD, Carter JM, Vierkant RA, et al
    Breast Cancer Risk and Progressive Histology in Serial Benign Biopsies.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available

  50. ERIKSEN KT, McElroy JA, Harrington JM, Levine KE, et al
    Urinary Cadmium and Breast Cancer: A Prospective Danish Cohort Study.
    J Natl Cancer Inst. 2017;109:1-7.
    PubMed     Text format     Abstract available

  51. GREENLEE H, Hershman DL, Shi Z, Kwan ML, et al
    BMI, Lifestyle Factors and Taxane-Induced Neuropathy in Breast Cancer Patients: The Pathways Study.
    J Natl Cancer Inst. 2017;109:1-8.
    PubMed     Text format     Abstract available

  52. WALTER JR, Xu S, Woodruff TK
    A Call for Fertility Preservation Coverage for Breast Cancer Patients: The Cost of Consistency.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available

  53. NOLAN E, Vaillant F, Visvader JE, Lindeman GJ, et al
    RE: Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers.
    J Natl Cancer Inst. 2017 Apr 4. doi: 10.1093.
    PubMed     Text format    

  54. WU X, Ye Y, Barcenas CH, Chow WH, et al
    Personalized Prognostic Prediction Models for Breast Cancer Recurrence and Survival Incorporating Multidimensional Data.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available

  55. ROJAS PA, May M, Sequeira GR, Elia A, et al
    Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin Responsiveness.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available

  56. SCHERNHAMMER ES
    RE: Night Shift Work and Breast Cancer Incidence: Three Prospective Studies and Meta-analysis of Published Studies.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format    

  57. GOETZ MP, Kalari KR, Suman VJ, Moyer AM, et al
    Tumor Sequencing and Patient-Derived Xenografts in the Neoadjuvant Treatment of Breast Cancer.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available

  58. HANSEN J
    RE: Night Shift Work and Breast Cancer Incidence: Three Prospective Studies and Meta-analysis of Published Studies.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format    


    J Nucl Med

  59. GROHEUX D
    18F-Fluoroestradiol PET to Predict the Response to Neoadjuvant Treatment of Luminal Breast Cancer.
    J Nucl Med. 2017;58:683.
    PubMed     Text format    

  60. DONOHOE KJ, Cohen EJ, Giammarile F, Grady E, et al
    Appropriate Use Criteria for Bone Scintigraphy in Prostate and Breast Cancer: Summary and Excerpts.
    J Nucl Med. 2017;58:14N-17N.
    PubMed     Text format    


    JAMA

  61. SACKEIM MG
    Eradicating a Genetic Mutation.
    JAMA. 2017;317:809.
    PubMed     Text format    


    Lancet Oncol

  62. FOUAD TM, Barrera AM, Reuben JM, Lucci A, et al
    Inflammatory breast cancer: a proposed conceptual shift in the UICC-AJCC TNM staging system.
    Lancet Oncol. 2017;18:e228-e232.
    PubMed     Text format     Abstract available


    Oncogene

  63. COHEN N, Shani O, Raz Y, Sharon Y, et al
    Fibroblasts drive an immunosuppressive and growth-promoting microenvironment in breast cancer via secretion of Chitinase 3-like 1.
    Oncogene. 2017 Apr 3. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    Oncol Rep

  64. HUANG Y, Jiang D, Sui M, Wang X, et al
    Fulvestrant reverses doxorubicin resistance in multidrug-resistant breast cell lines independent of estrogen receptor expression.
    Oncol Rep. 2017;37:705-712.
    PubMed     Text format     Abstract available


    PLoS One

  65. GUIMARAES E, Machado R, Fonseca MC, Franca A, et al
    Inositol 1, 4, 5-trisphosphate-dependent nuclear calcium signals regulate angiogenesis and cell motility in triple negative breast cancer.
    PLoS One. 2017;12:e0175041.
    PubMed     Text format     Abstract available

  66. ZHAO M, Howard EW, Guo Z, Parris AB, et al
    p53 pathway determines the cellular response to alcohol-induced DNA damage in MCF-7 breast cancer cells.
    PLoS One. 2017;12:e0175121.
    PubMed     Text format     Abstract available

  67. FANG S, Tian H, Li X, Jin D, et al
    Clinical application of a microfluidic chip for immunocapture and quantification of circulating exosomes to assist breast cancer diagnosis and molecular classification.
    PLoS One. 2017;12:e0175050.
    PubMed     Text format     Abstract available


    Radiology

  68. KIM SY, Han BK, Kim EK, Choi WJ, et al
    Breast Cancer Detected at Screening US: Survival Rates and Clinical-Pathologic and Imaging Factors Associated with Recurrence.
    Radiology. 2017 Apr 6:162348. doi: 10.1148/radiol.2017162348.
    PubMed     Text format     Abstract available


    Radiother Oncol

  69. REHAMMAR JC, Jensen MB, McGale P, Lorenzen EL, et al
    Risk of heart disease in relation to radiotherapy and chemotherapy with anthracyclines among 19,464 breast cancer patients in Denmark, 1977-2005.
    Radiother Oncol. 2017 Mar 29. pii: S0167-8140(17)30108.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: